Nature retracts study touted as step toward treatments for bone diseases

A Nature study that could have provided a “potential therapeutic target for osteoporosis and bone metastases of cancer” has been retracted.

Since being published in 2014 by researchers at UT Southwestern, MD Anderson and elsewhere, “miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2” has been cited more than 200 times, according to Clarivate Analytics’ Web of Science.

A year ago — on May 24, 2019 — Nature published a correction to the paper:

Continue reading Nature retracts study touted as step toward treatments for bone diseases

‘Negligence’ — a lot of it — leads to a retraction

Source

Some words do more work in sentences than others. Take the example of the word  “negligence,” which in the case of the following retraction notice is a veritable beast of burden.

The 2019 article, “Conservative management of subglottic stenosis with home based tracheostomy care: A retrospective review of 28 patients,” appeared in the International Journal of Pediatric Otorhinolaryngology, an Elsevier title. The authors, led by Andrew Pelser, have affiliations in the United Kingdom and South Africa — a fact that appears to be non-trivial. 

Per the abstract: 

Continue reading ‘Negligence’ — a lot of it — leads to a retraction

A journal publishes a critical letter — then says it was a mistake

On Sept. 17, 2019, virologist David Sanders — who recently won a lawsuit brought against him for efforts as a scientific sleuth — wrote a letter to the Journal of Cellular Physiology about a 2004 paper whose images raised his eyebrows.

The response a day later from an editorial assistant was a hint of what was to come:

Continue reading A journal publishes a critical letter — then says it was a mistake

Covid-19 and sex? Rapid-fire acceptance leads to hasty withdrawal of paper

The Journal of the American Academy of Dermatology has taken down a letter on whether people should abstain from sex during the coronavirus pandemic, but the editor says the article is not being retracted. 

Meanwhile, researchers in France have retracted a paper in which they’d claimed to have found  replication of the virus that causes Covid-19 in the dialysis fluid of a patient with kidney disease. Again, hasty publication appears to be involved. We’ve been tracking retractions of Covid-19 articles on our website, and, let’s just say, the list is almost certainly a trailing indicator of the robustness of the science here — as it is with retractions during any period.

Back to the letter. “COVID-19: Should sexual practices be discouraged during the pandemic?” was written by ZhiQiang Yin, of the Department of Dermatology at the First Affiliated Hospital of Nanjing Medical University, in China. Yin submitted the article on April 14. The journal accepted it on the 16th and published it on April 30th. 

According to the notice

Continue reading Covid-19 and sex? Rapid-fire acceptance leads to hasty withdrawal of paper

Too hot to handle: Authors retract Science paper on electromagnetics

Sometimes scientific findings can be too hot to handle. Literally. 

A team of researchers in India and Japan who reported breakthrough results in two papers about electromagnetics, including an article in Science, are retracting the articles because the exciting data resulted from experimental error. To be precise: unbeknownst to them, inadvertent heating of their samples had contaminated their data. 

The first author of both articles is Chanchal Sow, of the Indian Institute of Technology in Kanpur. The last author on both is Yoshiteru Maeno, a professor of physics at Kyoto University. 

Here’s the notice:

Continue reading Too hot to handle: Authors retract Science paper on electromagnetics

Former UCSD prof who resigned amid investigation into China ties has paper flagged for using the wrong test

Kang Zhang

Science Translational Medicine has issued an expression of concern about a 2020 paper on the genetics of colorectal cancer by a group in China whose results were pegged on a test that couldn’t have produced the findings. 

The article, “Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer,” appeared in January, with authors from both academia and an outfit called the Guangzhou Youze Biological Pharmaceutical Technology Company. 

Continue reading Former UCSD prof who resigned amid investigation into China ties has paper flagged for using the wrong test

A year after a university asked two Elsevier journals to retract papers, they haven’t

How long should a retraction take?

As Retraction Watch readers may recall, that’s a question we ask often. In 2018, for example, we wrote a post noting that nearly two years after the University of Maryland, Baltimore, had requested retractions, the journals had done nothing. Some of the papers have since been retracted.

We have occasion to ask the question again, about a different case at the University of Maryland. 

Continue reading A year after a university asked two Elsevier journals to retract papers, they haven’t

Elsevier investigating hydroxychloroquine-COVID-19 paper

Elsevier has weighed in on the handling of a controversial paper about the utility of hydroxychloroquine to treat Covid-19 infection, defending the rigor of the peer review process for the article in the face of concerns that the authors included the top editor of the journal that published the work. 

On April 3, as we reported, the International Society of Antimicrobial Chemotherapy issued an expression of concern (without quite calling it that) about the paper, which had appeared in March in the International Journal of Antimicrobial Agents, which the ISAC publishes, along with Elsevier. According to the society, the article, by the controversial French scientist  Didier Raoult, of the University of Marseille, and colleagues:

Continue reading Elsevier investigating hydroxychloroquine-COVID-19 paper

Authors aren’t happy to lose four more papers in chemistry journals

Gauhati University, via Wikimedia

A pair of researchers in India with a history of stealing a paper from other authors during the peer review process have lost four more articles, this time for questionable data. 

The papers, by Priyadarshi Roy Chowdhury and Krishna G. Bhattacharyya, of Gauhati University in Jalukbari, appeared in journals published by the UK’s Royal Society of Chemistry. At least some of the hijinks by the pair resulted in a misconduct inquiry by the institution — the report of which one of the authors told Retraction Watch “was completely one-sided and vindictive.”

One of the papers, “Ni/Co/Ti layered double hydroxide for highly efficient photocatalytic degradation of Rhodamine B and Acid Red G: a comparative study,” was published in 2017 in Photochemical & Photobiological Sciences. According to the notice

Continue reading Authors aren’t happy to lose four more papers in chemistry journals

A snake bites once, but its picture is used twice

via BMC Emergency Medicine

For some people, a venomous snake is a venomous snake — and evidently, some of those people include journal editors.  

The authors of a 2019 case report describing the unfortunate case of an African farmer killed by the bite of a lethal snake have lost the article because the mug shot of the reptilian culprit didn’t match its description in the paper. 

The paper, “Severe Viperidae envenomation complicated by a state of shock, acute kidney injury, and gangrene presenting late at the emergency department: a case report,” appeared in BMC Emergency Medicine, a Springer Nature title. 

Continue reading A snake bites once, but its picture is used twice